Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02529553
Title A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
The START Center for Cancer Care San Antonio Texas 78229 United States Details
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Vancouver British Columbia V5Z 4E6 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field